Prevalence and characteristics of hip involvement in spondyloarthritis: A single-centre observational study of 275 patients

Clinical and Experimental Rheumatology

Volumn 30, Issue 4, 2012, Pages 481-486

  Burki, V ^a   Gossec, L ^a   Payet, J ^a   Durnez, A ^a   Elhai, M ^a   Fabreguet, I ^a   Koumakis, E ^a   Meyer, M ^a   Paternotte, S ^a   Roure, F ^a   Dougados, M ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Hip involvement; Prevalence; Spondylarthritis

Indexed keywords

HLA B27 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COXITIS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HIP ARTHROPLASTY; HIP PAIN; HIP RADIOGRAPHY; HIP SURGERY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; SPONDYLARTHRITIS;

ADULT; ARTHRALGIA; ARTHRITIS; ARTHROPLASTY, REPLACEMENT, HIP; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HIP JOINT; HUMANS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPONDYLARTHRITIS; YOUNG ADULT;

EID: 84867350817     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Appel H, Nuhne M, Spiekermann S et al. Immunohistochemical analysis of hip arthritis in ankylosing spondylitis. Arthritis Rheum 2006; 54: 1805-13.
2. Chen WS, Chen CH, Lin KC et al. Immunohistological features of hip synovitis in anklyosing spondylitis with advanced hip involvement. Scand J Rheumatol 2009; 38: 154-58.
3. Calin A, Elswood J The relationship between pelvic, spinal and hip involvement in ankylosing spondyliti - one disease process or several? Br J Rheumatol 1998; 27: 393-5.
4. Amor B, Santos RS, Nahal R, Listrat V, Dougados M Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol 1994; 21: 1883-7.
5. Braun J Epidemiology and prognostic aspects of ankylosing spondylitis. Radiologe 2004; 44: 209-10, 212-6.
6. Brophy S, Calin A Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol 2001; 28: 2283-8.
7. Mathur T, Manadan AM, Hota B, Block JA Pseudo-septic hip arthritis as the presenting symptom of ankylosing spondylitis: a case series and review of the literature. Clin Exp Rheumatol 2010; 28: 416-8.
8. Chen HA, Chen CH, Liao HT et al. Factors associated with radiographic spinal involvement and hip involvement in ankylosing spondylitis. Semin Arthritis Rheum 2011; 40: 552-8.
9. Van Der Cruyssen B, Munoz-Gomariz E, Font P et al. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology 2010; 49: 73-81.
10. Michet CJ, Mason TG, Mazlumzadeh M Hip joint disease in psoriatic arthritis: risk factors and natural history. Ann Rheum Dis 2005; 64: 1068-70.
11. Elhai M, Paternotte S, Roure F et al. Anterior chest wall pain in spondyloarthritis is a frequent manifestation, appearing early in the disease course, which may respond to NSAIDs. [abstract]. Arthritis Rheum 2010; 62 (Suppl. 10): 1924.
12. Amor B, Dougados M, Mijiyawa M Critères de classification des spondylar-thropathies Rev Rhum Mal Osteoart 1990; 57: 85-9.
13. Rudwaleit M, Van Der Heijde D, Landewé R et al. The development of Assessment of Spondylarthritis International Society (ASAS) Classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis 2009; 68: 777-83.
14. Van Der Linden SM, Valkenburg HA, Cats A Evaluation of the diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
15. Calin A, Garrette S, Whitelock H et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 2281-5.
16. Gensler LS, Ward MM, Reveille JD, Learch TJ, Weisman MH, Davis Jr. JC Clinical, radiographic and functional differences between juvenile-onset and adult-onset ankylosing spondylitis: results from the PSOAS cohort. Ann Rheum Dis 2008; 67: 233-37.
17. Haijaj-Hassouni N, Maetzel A, Dougados M, Amor B Comparison of patients evaluated for spondylarthropathy in France and Morocco. Rev Rhum Ed Fr 1993; 60: 420-5.
18. Claudepierre P, Gueguen A, Ladjouze A et al. Predictive factors of severity of spondyloarthropathy in North Africa. Br J Rheumatol 1995; 34: 1139-45.
19. Singh G, Lawrence A, Agarwal V, Misra R, Aggarwal A Higher prevalence of extra-articular manifestations in ankylosing spondylitis with peripheral arthritis. J Clin Rheumatol 2008; 14: 264-6.
20. Baek HJ, Shin KC, Lee YJ et al. Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD. Rheumatology 2004; 43: 1526-31.
21. Verbruggen G Chondroprotective drugs in degenerative joint diseases. Rheumatology 2006; 45: 129-38.
22. Baraliakos X, Braun J Hip involvement in ankylosing spondylitis. Rheumatology 2010; 49: 3-4.
23. Doran MF, Brophy S, Mackay K, Taylor G, Calin A Predictors of long term outcome in ankylosing spondylitis. J Rheumatol 2003; 30: 316-20.
24. Joshi AB, Markovic L, Hardinge K, Murphy JC Total hip arthroplasty in ankylosing spondylitis. J Arthroplasty 2002; 17: 427-33.
25. Brinker MR, Rosenberg AG, Kull L, Cox DD Primary noncemented total hip arthroplasty in patients with ankylosing spondylitis. Clinical and radiographic results at an average follow-up period of 6 years. J Arthroplasty 1996; 11: 802-12.
26. Chong RW, Chong CS, Lai CH Total hip arthroplasty in patients with chronic autoimmune inflammatory arthroplasties. Int J Rheum Dis 2010; 13: 235-9.